Pharmacology of Inflammatory Bowel Disease
Pharmacology of Inflammatory Bowel Disease is organized by Nurse.com - OnCourse Learning Corporation.
Course Originally Released on: 05/25/2023
Date of Most Recent Review: 5/25/2023
Course Termination/ Update Date: 12/31/2026
Description:
Inflammatory bowel disease (IBD) is a chronic disorder involving an abnormal immune reaction to specific components of the gastrointestinal (GI) tract. The two primary forms of IBD are Crohn’s disease (CD) and ulcerative colitis (UC). In the U.S., approximately 3.1 million people have been diagnosed with one of these two forms of IBD (CDC, 2022).
Goal and Learning Outcomes:
The goal of this course is to update healthcare team members with knowledge of pharmacological treatment plans for IBD to aid awareness of new guidelines.
After taking this course, you should be able to:
• Identify the role of clinical presentation and IBD severity in pharmacological treatment decision making.
• Identify two classes of drugs for the management of IBD.
• Recall the indications, contraindications, and common adverse effects of drugs used to treat IBD.